Hyperliquid Strategies (PURR) Stock Price, News & Analysis

Company Overview

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc., is based in NEW YORK.

Key Stats

• Today's Range: $6.48 to $6.87
• 50-Day Range: $3.78 to $6.70
• 52-Week Range: $3.01 to $6.88
• Volume: 8.81 million shs
• Average Volume: 5.64 million shs
• Market Capitalization: $830.97 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.15
• Consensus Rating: Moderate Buy

Hyperliquid Strategies Stock Analysis - MarketRank™

Hyperliquid Strategies scored higher than 39% of companies evaluated by MarketBeat, and ranked 33rd out of 59 stocks in the manufacturing sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Hyperliquid Strategies has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 2 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Hyperliquid Strategies has a consensus price target of $8.15, representing about 21.6% upside from its current price of $6.70.

Amount of Analyst Coverage

Hyperliquid Strategies has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Hyperliquid Strategies are expected to grow in the coming year, from ($1.15) to $3.02 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Hyperliquid Strategies is -0.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Hyperliquid Strategies is -0.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Hyperliquid Strategies has a P/B Ratio of 4.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for PURR.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Hyperliquid Strategies does not currently pay a dividend.

Dividend Growth

Hyperliquid Strategies does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

Search Interest

6 people have searched for PURR on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.

MarketBeat Follows

3 people have added Hyperliquid Strategies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Hyperliquid Strategies insiders have not sold or bought any company stock.

Percentage Held by Insiders

8.48% of the stock of Hyperliquid Strategies is held by insiders.

Percentage Held by Institutions

9.45% of the stock of Hyperliquid Strategies is held by institutions.

PURR Stock Analysis - Frequently Asked Questions

How have PURR shares performed this year?

Hyperliquid Strategies' stock was trading at $4.63 at the beginning of 2026. Since then, PURR stock has increased by 44.8% and is now trading at $6.7030.

How were Hyperliquid Strategies' earnings last quarter?

Hyperliquid Strategies Inc (NASDAQ:PURR) announced its quarterly earnings data on Wednesday, February, 11th. The company reported ($7.43) earnings per share for the quarter. The firm had revenue of $0.50 million for the quarter.
Read the conference call transcript.

Who are Hyperliquid Strategies' major shareholders?

Top institutional investors of Hyperliquid Strategies include Bank of New York Mellon Corp (0.02%), SG Americas Securities LLC (0.02%) and Private Advisor Group LLC (0.01%).

How do I buy shares of Hyperliquid Strategies?

Shares of PURR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 2/11/2026
• Today: 5/05/2026
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: N/A
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PURR
• CIK: 2078856
• Web: www.sonnetbio.com
• Phone: (212) 883-4330
• Fax: 704-366-2463
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Hyperliquid Strategies: $8.15
• High Price Target: $10.00
• Low Price Target: $6.00
• Potential Upside/Downside: +21.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($9.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.01 million
• Net Margins: N/A
• Pretax Margin: -59,891.80%
• Return on Equity: -212.19%
• Return on Assets: -199.12%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 31.62
• Quick Ratio: 31.62

Sales & Book Value

• Annual Sales: $1 million
• Price / Sales: 830.97
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.52 per share
• Price / Book: 4.41

Miscellaneous

• Outstanding Shares: 123,970,000
• Free Float: 113,456,000
• Market Cap: $830.97 million
• Optionable: N/A
• Beta: 1.44